investigators concluded that results suggest that aerobic NMES may have a beneficial effect on A1c of men with diabetes. The treatment may be of particular benefit in those who will not or cannot do adequate amounts of voluntary exercise.
After careful review of the study, some important revisions are suggested as follows.
1) The abstract refers to weight loss and lean mass gains. However, there were no statistically significant differences in the pre-post values by paired-t-test. Please add p values for clarity regarding the inference of the estimations.
2) The authors refer to this as the "first study to used these new NMES techniques" (page 4. Line 52). However, given this is a pilot investigation not based on a randomized controlled trial (RCT) the enthusiastic characterization of this statement should be reconsidered.
3) There needs to be a description of how many subjects were approached for those ultimately enrolled in the study. How many refusals, drop outs, etc. Given the small sample size this information is needed to make sure that subjects who chose to enroll in the study were not different from those who refused in terms of their motivation, self management and health consciousness…because all of which would bias the results toward a benefit. 4) Regarding the aerobic NMES intervention: How was accommodation and habituation to the NEMS device tested? How was breathing and sweat quanti/qualified by the subjects? How was the target heart rate of 120 determined? How long was the introductory session? Where there any drop puts after it?
5) The main outcome, A1c, is based on an n of 8 where one subject's data was calculated from fructosamine. I suggest the analysis is only based on the 7 subjects for whom A1c data are available pre and post study. 6) How was the qualitative data of the questionnaire handled? Were measured taken in a blinded fashion? 7) There needs to be a section on statistical analysis in the methods.
8) The last sentence of the first paragraph in the discussion alludes to the lack of change in diet or lifestyle. However, there were not data collected on dietary intake or physical activity to back this up. 9) Given the sample size and study design, this pilot study can not conclusively provide evidence base information on the efficacy of aerobic NMES. Therefore, I suggest the discussion be revised to take into account these study limitations, which should also be mentioned. Why was 6-8 weeks used, as HbA1c normally takes longer than that to improve? I am unclear as to whether they were asked to use it for 6 or 8 weeks. One patient does much better than the others with a fall of HbA1c by 2% if this patient is removed from the analysis does this effect the result?
10) Add p values to
Discussion There needs to be more discussion about their results and how these compare to other studies. The effect is very varied some patients seeing a 2% fall others seeing no effect. Similarly some patients are gaining huge amount of lean mass and others losing lean mass. Why such differences?
In this study patients had to use the machine 6 times a week, where as in exercise studies they are typically asked to exercise 3 times a week. Is there any data on long term adherence to these machines and this frequency of use? I am not sure that arthritis has been shown to be an impediment to exercise, data does suggest that it may reduce uptake of exercise regimes but not that it prevents it completely.
Descriptions of measures should be consistent -HbA1c or glycosylated haemoglobin. Could the following wording be looked at;
• Impediment -this is a term usually used for speech • "Aggressive intensities" -do you mean this • "in the obese" -should it not be in the patient with obesity.
• "…using their system" -this reads like they are your competitorsshould it not be "..using other systems".
Patients and Methods I am unclear as to how the participants for this study were selected and how representative they are of the average patients with diabetes. More detail in needed about the selection process and about the demographics of the patients, for example
• Why were only men examined?
• Why were the particular inclusion criteria chosen?
• How were "suitable potential patients chosen"?
• How many people volunteered and what were the reasons for not being included?
• What medication were the patients on?
Why was 6-8 weeks used, as HbA1c normally takes longer than that to improve? I am unclear as to whether they were asked to use it for 6 or 8 weeks.
Were any measures of activity or diet measured during the study? One patient does much better than the others with a fall of HbA1c by 2% if this patient is removed from the analysis does this effect the result?
In this study patients had to use the machine 6 times a week, where as in exercise studies they are typically asked to exercise 3 times a week. Is there any data on long term adherence to these machines and this frequency of use?
What are the next steps to validate the use of these machines? 
Methods
The Methods section should be split into different sub-headings, such as "participants" and "procedure", also details of the "Statistical Analysis" needs to be described. P.5.L.13-21: It would be better to indicate the number of participants here and also specify the age, height, weight and BMI as Mean (SD) instead of range. The activity level of each participant should also be described, since this could be a confound to the actual benefit of the NMES intervention over the 6-8 weeks. P.5.L.19: Specify the details of typical "oral medications"? P.5.L.34-36: What were the stimulation parameters used to reach the ~120BPM heart rate in the introductory session, and were these stimulation parameters used by each subject for their individual NMES training sessions? P. 
